Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Treatment of anaplastic glioma, , and . Cancer Treat Res, (2015)NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide, , , , , , , , , and 10 other author(s). J Clin Oncol, 27 (35): 5874-5880 (December 2009)Tweety-Homolog 1 Drives Brain Colonization of Gliomas, , , , , , , , , and 12 other author(s). J Neurosci, 37 (29): 6837-6850 (July 2017)Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match (N2M2) pilot study, , , , , , , , , and 11 other author(s). Neuro Oncol, 20 (6): 826-837 (May 2018)ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma, , , , , , , , , and 9 other author(s). Acta Neuropathol, 129 (1): 133-146 (January 2015)A comprehensive analysis of vascular complications in 3,889 glioma patients from the German Glioma Network, , , , , , , , , and 1 other author(s). J Neurol, 260 (3): 847-855 (March 2013)Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells, , , , , , , and . J Neurochem, 122 (2): 444-455 (July 2012)Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities, , , , , , , , , and 17 other author(s). Acta Neuropathol, 130 (3): 407-417 (September 2015)Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations, , , , , , , , , and 46 other author(s). Acta Neuropathol, (March 2018)N2M2 (NOA20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma, , , , , , , , , and 9 other author(s). Neuro Oncol, (October 2018)